CBLL Q4 2024 Earnings — CeriBell, Inc. Revenue & Financial Results | Market Cap Arena

CBLLCeriBell, Inc.

$704M

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$19M+41.1% YoY

Gross Profit

$16M87.6% margin

Operating Income

-$13M-69.5% margin

Net Income

-$13M-67.9% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

+7.8%

Cash Flow

Operating Cash Flow

-$10M

Free Cash Flow

-$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$225M

Total Liabilities

$34M

Stockholders' Equity

$191M

Cash & Equivalents

$194M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$13M	+41.1%
Gross Profit	$16M	$11M	+46.1%
Operating Income	-$13M	-$8M	-53.7%
Net Income	-$13M	-$8M	-52.0%